Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults

Radiographics

Volumn 26, Issue SPEC. ISS., 2006, Pages

  Al Okaili, Riyadh N ^a   Krejza, Jaroslaw ^a,b   Wang, Sumei ^a   Woo, John H ^a   Melhem, Elias R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BRAIN; BRAIN TUMOR; CLINICAL PRACTICE; COMPUTER ASSISTED DIAGNOSIS; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; PATHOLOGY; PRACTICE GUIDELINE; REVIEW;

ALGORITHMS; BRAIN; BRAIN NEOPLASMS; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 34247503858     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.26si065513     Document Type: Review

References (50)

1. Tilgner J, Herr M, Ostertag C, Volk B. Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis - influence of clinical factors. Neurosurgery 2005;56(2):257-263.
2. Perez-Cruet MJ, Adelman L, Anderson M, Roth PA, Ritter AM, Saris SC. CT-guided stereotactic biopsy of nonenhancing brain lesions. Stereotact Funct Neurosurg 1993;61(3):105-117.
3. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84(3):449-458.
4. Tien RD, Lai PH, Smith JS, Lazeyras F. Single-voxel proton brain spectroscopy exam (PROBE/SV) in patients with primary brain tumors. AJR Am J Roentgenol 1996;167(1):201-209.
5. Butzen J, Prost R, Chetty V, et al. Discrimination between neoplastic and nonneoplastic brain lesions by use of proton MR spectroscopy: the limits of accuracy with a logistic regression model. AJNR Am J Neuroradiol 2000;21(7):1213-1219.
6. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24(10):1989-1998.
7. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo H-1 magnetic resonance spectroscopy. Magn Reson Med 2003;49(2):223-232.
8. Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002;44(5):371-381.
9. Galanaud D, Chinot O, Nicoli F, et al. Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. J Neurosurg 2003;98(2):269-276.
10. Gupta RK, Sinha U, Cloughesy TF, Alger JR. Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med 1999;41(1):2-7.
11. Lai PH, Ho JT, Chen WL, et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol 2002;23(8):1369-1377.
12. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92(24):2029-2036.
13. Yang D, Korogi Y, Sugahara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI. Neuroradiology 2002;44(8):656-666.
14. Lam WW, Poon WS, Metreweli C. Diffusion MR imaging in glioma: does it have any role in the preoperation determination of grading of glioma? Clin Radiol 2002;57(3):219-225.
15. Aronen HJ, Pardo FS, Kennedy DN, et al. High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res 2000;6(6): 2189-2200.
16. Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood-volume mapping of gliomas: clinical utility. Acta Radiol 1995;36(5):520-528.
17. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood-volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191(1):41-51.
18. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211(3):791-798.
19. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004;25: 214-221.
20. Burtscher IM, Skagerberg G, Geijer B, Englund E, Stahlberg F, Holtas S. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 2000;21(1):84-93.
21. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002; 222(3):715-721.
22. Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003;24(5):937-941.
23. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echoplanar perfusion MR imaging. Radiology 2002; 223(1):11-29.
24. Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197(2):525-531. [Published correction appears in Radiology 1996;198(2):586.]
25. Simone IL, Federico F, Tortorella C, et al. Localised H-1-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 1998;64(4):516-523.
26. Chinn RJ, Wilkinson ID, Hall Craggs MA, et al. Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 1995;197(3):649-654.
27. Camacho DL, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNR Am J Neuroradiol 2003;24(4):633-637.
28. Sugahara T, Korogi Y, Shigematsu Y, et al. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. Top Magn Reson Imaging 1999;10(2): 114-124.
29. Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003;338(2): 119-122.
30. Ernst TM, Chang L, Witt MD, et al. Cerebral toxoplasmosis and lymphoma in AIDS: perfusion MR imaging experience in 13 patients. Radiology 1998;208(3):663-669.
31. Bitsch A, Bruhn H, Vougioukas V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 1999;20(9): 1619-1627.
32. Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002;23(8):1378-1386.
33. Bernarding J, Braun J, Koennecke HC. Diffusion-and perfusion-weighted MR imaging in a patient with acute demyelinating encephalomyelitis (ADEM). J Magn Reson Imaging 2002;15(1):96-100.
34. Gupta RK, Pandey R, Khan EM, Mittal P, Gujral RB, Chhabra DK. Intracranial tuberculomas: MRI signal intensity correlation with histopathology and localised proton spectroscopy. Magn Reson Imaging 1993;11(3):443-449.
35. Yamagata NT, Miller BL, McBride D, et al. In vivo proton spectroscopy of intracranial infections and neoplasms. J Neuroimaging 1994;4(1):23-28.
36. Remy C, Lebars E, Ibarrola D, Lai ES, Grand S, Decorps M. In-vivo imaging of metabolites using nuclear-magnetic-resonance spectroscopy. J Trace Microprobe Tech 1995;13(3):293-301.
37. Grand S, Passaro G, Ziegler A, et al. Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy - initial results. Radiology 1999;213(3):785-793.
38. Burtscher IM, Holtas S. In vivo proton MR spectroscopy of untreated and treated brain abscesses. AJNR Am J Neuroradiol 1999;20(6):1049-1053.
39. Garg M, Gupta RK, Husain M, et al. Brain abscesses: etiologic categorization with in vivo proton MR spectroscopy. Radiology 2004;230(2): 519-527.
40. Lai PH, Li KT, Hsu SS, et al. Pyogenic brain abscess: findings from in vivo 1.5-T and 11.7-T in vitro proton MR spectroscopy. AJNR Am J Neuroradiol 2005;26(2):279-288.
41. Chang SC, Lai PH, Chen WL, et al. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. Clin Imaging 2002;26(4):227-236.
42. Ebisu T, Tanaka C, Umeda M, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 1996;14(9):1113-1116.
43. Chan JH, Tsui EY, Chau LF, et al. Discrimination of an infected brain tumor from a cerebral abscess by combined MR perfusion and diffusion imaging. Comput Med Imaging Graph 2002; 26(1):19 -23.
44. Sener RN. Rasmussen's encephalitis: proton MR spectroscopy and diffusion MR findings. J Neuroradiol 2000;27(3):179-184.
45. Takanashi J, Sugita K, Ishii M, Aoyagi M, Niimi H. Longitudinal MR imaging and proton MR spectroscopy in herpes simplex encephalitis. J Neurol Sci 1997;149(1):99-102.
46. Tsuchiya K, Katase S, Yoshino A, Hachiya J. Diffusion-weighted MR imaging of encephalitis. AJR Am J Roentgenol 1999;173(4):1097-1099.
47. Nonaka M, Ariyoshi N, Shonai T, et al. CT perfusion abnormalities in a case of non-herpetic acute limbic encephalitis [in Japanese]. Rinsho Shinkeigaku 2004;44(8):537-540.
48. Launes J, Lindroth L, Liewendahl K, Nikkinen P, Brownell AL, Iivanainen M. Diagnosis of acute herpes simplex encephalitis by brain perfusion single photon emission computed tomography. Lancet 1988;1(8596):1188-1191.
49. Runge VM, Muroff LR, Jinkins JR. Central nervous system: review of clinical use of contrast media. Top Magn Reson Imaging 2001;12(4):231-263.
50. Cha S, Pierce S, Knopp EA, et al. Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2001;22(6):1109-1116.